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Abstract 
Antibiotic resistance is a serious problem in S. epidermidis infections since many clinical isolates of this 
organism are resistant up to eight different antibiotics.The increased resistance to conventional 
antibiotic therapy has lead to the search for new antimicrobial therapeutic agents. Farnesol, an 
essential oil found in many plants, has been shown to be active against S. epidermidis. Using a 
typecontrol strain we recently described that while farnesol was not efficient at killing biofilm bacteria, a 
strong reduction on biofilm biomass was detected, and we hypothesize that farnesol could, somehow, 
induce biofilm detachment. In this report, to test our hypothesis we used 36 representative clinical 
strains of S. epidermidis from different geographic locations and characterized them in terms of genetic 
variability by MLST and SSCmec. Strains were tested for biofilm formation and the presence of ica, bhp 
and aap genes was determined. Stronger biofilms had always the presence of ica operon but often co-
harbored bhp and aap genes. Farnesol was then used in biofilm forming strains and biofilm detachment 
was detected in half of the strains tested. Furthermore, we also showed that farnesol inability to kill 
biofilm bacteria was not the result of the biofilm structure but was related to high cell density. Our 
results demonstrate, for the first time, that the biomass reduction previously found by us, and many 
other groups, is the result not of cell killing but instead is the result of biofilm detachment.  
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Introduction 
Staphylococcus epidermidis is a Gram-positive bacterium that normally colonizes the human skin and 
mucous membranes. Previously regarded as an innocuous commensal microorganism it is now seen 
as an important opportunistic pathogen, becoming,in the past few decades, the most frequent causative 
agent of nosocomial infections. This is mainly due to the increasing use of medical devices, allowing for 
biofilm formation in such surfaces 1. S. epidermidis biofilm-related infections normally begin with the 
introduction of bacteria from the skin of the patient or health care personnel during device insertion. 
While these infections rarely lead to mortality, they are associated with increased patient morbidity 1.An 
important aspect of the biofilm-related infections is their economic burden on the public health system 
at an annual cost of over 2 billion Dollar in the US alone 2. 
Microbial biofilms are communities of bacteria that live adhered to a surface and are surrounded by an 
extracellular polymeric matrix, in an increased antibiotic resistance and tolerance to the immune 
system3. Multiple mechanisms have been proposed for the high resistance of bacterial biofilms to 
antibiotics, including 1) the low diffusivity of antibiotics through the matrix, 2) the inactivation of the 
antibiotics by matrix components, 3) the presence of a sub-population of bacteria, known as persisters, 
that are unaffected by antibiotics, or 4) the heterogeneous nature of the biofilm composition and 
tridimensional structure 4.These mechanisms only partially explain the increased resistance and 
probably this phenotype is the result of more than one specific mechanism. 
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Increased bacterial resistance toward antibiotics has led to the search for new antimicrobial therapeutic 
agents such as essential oils from plants. Farnesol is a naturally-occurring sesquiterpene that was 
originally isolated from essential oils found in many plants 5. Farnesol has also been found to be 
produced by Candida spp, being involved in quorum sensing 6. Of high importance is the fact that 
farnesol has been shown to have antimicrobial potential against several bacteria, including S. 
epidermidis7.However, the mechanism of action of farnesol is not yet fully understood, but it seems to 
be related to cell membrane integrity 8.  
We recently described a bacterial strain where farnesol had no detectable antibiotic effect but strongly 
reduced biofilm biomass. We hypothesized that farnesol could be inducing biofilm detachment9. In this 
manuscript we tested this hypothesis and assayed the effect of farnesol in biofilm-forming clinical 
isolates of S. epidermidis, representing a wide diversity in terms of genetic background, geographic and 
clinical origins. 
 
Materials and Methods 
Bacterial strains  
Two well known biofilm-forming strains were selected to be used as control strains, based on our 
previous work:S. epidermidis 9142 biofilm biomass is reduced by farnesol while S. epidermidis 1457 
biofilms shows no reduction7.Furthermore, we also used 25 clinical strains previously characterized by 
several different molecular typing techniques, namely staphylococcal chromosome cassette mec 
(SCCmec) and multilocus sequence typing (MLST), were selected from a total of 217 nosocomial 
isolates collected between 1996 and 2001 in 17 different countries, from disease (107 isolates) and 
from carriage (87 isolates). Isolates were selected in order to include the highest diversity as possible in 
terms of genetic backgrounds, geographic and clinical origins. Finally a subset of 9 clinical strains 
isolated from indwelling devices in Boston, MA, USA, were also included. All strains are listed in the 
results section. 
 
Cell density and cell metabolism effect on farnesol antimicrobial activity 
Tryptic soy broth (TSB, Oxford, UK, 1 mL) was inoculated with one single colony of each S. epidermidis 
control strain, in a 10 mL sterile test tube and incubated at 37°C in a shaker at 120 rpm for 24 ± 2 h. 
Each bacterial suspension was gently sonicated on ice, at 8Wfor 10 s, with the sonicator tip placed at 
the air/liquid interface (Ultrasonic Processor, Cole-Parmer, USA). This treatment did not reduce cell 
cultivability. To test farnesol on stationary-phase planktonic cells, serial 10-fold dilutions were 
performed in 2 mL of fresh TSB supplemented with 300 µM of 96% pure trans-trans-farnesol from 
Sigma ((E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol, trans,trans-3,7,11-trimethyl-2,6,10-dodecatrien-
1-ol), a concentration previously optimized, and needed to affect S. epidermidis biofilms 7. A control was 
used where no farnesol was added. Each cell concentration was incubated for 4 hat 120 rpm at 37 ºC. 
Colony forming units (CFU) were determined by the standard plating method, using Tryptic Soy Agar 
(TSA) plates. To test farnesol on exponential-phase planktonic cells, serial 10-fold dilutions of inocula 
were performed in 2 mL of fresh TSB without farnesol. Each cell concentration was pre-incubated for 8 
h at 120 rpm at 37 ºC before 300 µM farnesol was added to the medium, except to the control. After 
adding farnesol, cells were allowed to incubate for additional 4 h in the same conditions, before 
determining CFUs. These experiments where repeated three to five times with duplicates. 
 
Biofilm quantification 
Biofilms were quantified using 3 different approaches. TSB was inoculated with one single colony of 
each S. epidermidis control strain, in a 10 mL sterile tube, and incubated at 37°C in a shaker at 120 rpm 
for 24 ± 2 h. Then a 1:200 dilution was performed in fresh TSB supplemented with 1% (w/v) of glucose 
(TSBG), and incubated at 37°C in a shaker at 120 rpm in 96 well culture plates (Orange Scientific, 
Braine-l’Alleud, Belgium) for 24 h. Biofilms were then washed twice with 0.9% NaCl and fresh TSBG 
was added with or without 300 µM of farnesol and allowed to incubate in the same conditions for further 
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24 h. For biofilm biomass determination, the standard crystal violet staining method was used as 
described elsewhere 10. To determine cell viability, biofilms were washed twice with 0.9% NaCl and 
resuspended in 0.9% NaCl followed by gentle sonication as described above. CFUs were determined 
by the standard plating method, using TSA plates. To determine the percentage of growth of bacteria 
inside the biofilm after 48 h, we quantified the relative population density of biofilms and the respective 
suspension formed during the last 24 h of growth, on each 96 well, as described before 11. These 
experiments were repeated three to five times with 8 replicates. 
 
Molecular characterization of the clinical strains 
All strains were characterized by multilocus sequence typing (MLST)following the scheme proposed by 
Thomas et al.12. The MLST data wereanalysed using the goeBURST algorithm 
(http://goeBURST.phylowiz.net).This analysis was performed on March 21st, 2012. Isolates were 
considered as belonging to the same clonal complex (CC) if sharing six out of seven loci.The SCCmec 
type was determined by the combination of the class of mec complex and the type of ccr complex. 
SCCmec was considered non-typable when either mec complex or ccr complex, or both, were non-
typable by the methods used or when the isolate carried more than one ccr type. SCCmec was 
considered to be new if a new combination of mec complex and ccr complex was found. The presence 
of the genes associated to biofilm formation, namely icaA, aap and bhp was detected by PCR, using 
DyNAzyme II PCR mix (Finnzymes, Vantaa, Finland), in the following thermal conditions: initial 
denaturation at 94ºC for 5 min followed by 35 cycles of 94ºC at 30 s, 54ºC at 30 s and 72ºC at 45 s. A 
final extension step was performed for 10 min at 72 ºC. Negative results were re-checked with a second 
set of primers. Oligonucleotide primers were designed using the Primer3 software, having S. 
epidermidis RP62A genome as template: icaA (Fw - tgcactcaatgagggaatca, Rv- tcaggcactaacatccagca; 
amplicon size of 417), aap (Fw - gctctcataacgccacttgc, Rv - ggacagccacctggtacaac; amplicon size of 
617), bhp (Fw - tggactcgtagcttcgtcct, Rv - tctgcagatacccagacaacc; amplicon size of 213).For biofilm 
biomass determination, the standard crystal violet staining method was used 10.  
 
Statistical analysis 
All the assays were compared using the paired sample t-test, using SPSS. All tests were performed 
with a confidence level of 95%. 
 
Results 
Effect of farnesol on established biofilms 
To better understand the effect of farnesol on biofilm physiology, we characterized three different 
parameters on the biofilm formation ability of S. epidermidis exposed to farnesol: 1) biofilms were 
quantified regarding biomass accumulation, 2) viable cell concentration and also by the 3) percentage 
of bacteria that grew in the biofilm mode.S. epidermidis 9142 (farnesol susceptible) and S. epidermidis 
1457 (farnesol tolerant) biofilms were formed and exposed to 300 µM of farnesol. Biofilms were initially 
grown for 24 h, after which the medium was removed and replaced by fresh TSBG or TSBG 
supplemented with 300 µM of farnesol. As can be seen in Figure 1 only strain 9142 was significantly 
affected by farnesol (paired samples t-test, p<0.05). While there was a significant reduction in the 
biofilm biomass (paired samples t-test, p<0.05), the total number of viable cells was not affected. 
Interestingly, in the presence of farnesol, there was a significant (paired-samples t-test, p<0.05) 
increase of 44.1% in the number of cells living outside the S. epidermidis 9142 biofilm. 
 
The effect of cell density and metabolic activity on farnesol activity against planktonic cells  
To further understand the action of farnesol on planktonic cells, populations of bacteria at different cell 
concentrations and in different growth phases were exposed to 300 µM of farnesol for 4 h, after which 
viable bacteria were determined. The killing rate was defined as the logarithmic difference between 
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viable bacteria after the 4 h treatment and the viable bacteria before the treatment with farnesol. The 
data shown in Table 1 indicate that farnesol had no effect on stationary-phase populations equal or 
above 108 CFU/mL. However, in diluted cell populations, approximately 90% of bacteria were killed 
during the 4 h test. In log phase, at a cell density of 109 and 108 cells/mL (resulting from the initial 
inocula of 107 and 106 CFU/mL) farnesol showed a bacteriostatic effect, reducing cell growth, but not 
killing bacteria. Similarly to the stationary-phase planktonic populations, at cell densities bellow 107 
CFU/mL, farnesol killed around 90% of bacteria.  
 
Figure 1 | Effect of farnesol on S. epidermidis biofilms. Bacteria were allowed to form biofilms for 24 
h, after which fresh medium was added with or without 300 µM of farnesol and allowed to grow for 
further 24 h. Top: crystal violet staining; middle: CFUs determination; bottom: percentage of planktonic 
cells living outside the biofilms.* significant difference, paired samples t-student, p<0.05. 
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Table 1 | Effect of farnesol exposure on planktonic cells in stationary or exponential phase at 
different concentrations, expressed as the logarithmic variation of cell number during the 4 h 
exposure time to farnesol. Stationary planktonic cells were grown for 24 h in TSB, and then diluted 
down in fresh TSB and allowed to grow for 4 h in the presence of farnesol. Log phase cells were grown 
for 24 h, and then diluted in fresh TSB after which they were grown for another 8 h before adding 
farnesol. After farnesol exposure, cells were allowed to grow for more 4 h.  *significant bactericidal 
effect or **significant bacteriostatic effect (paired samples t-student, p<0.05). 
 Stationary phase Log phase 
Inoculum cell density control farnesol control farnesol 
109 / mL 0.27 ± 0.13 0.14 ± 0.13 N/A N/A 
108 / mL 0.24 ± 0.26 0.02 ± 0.30 N/A N/A 
107 / mL 0.13 ± 0.26* -1.12 ± 0.41* 0.85 ± 0.10** 0.03 ± 0.07** 
106/ mL 0.75 ± 0.56* -1.42 ± 0.76* 1.56 ± 0.27** 0.29  ± 0.27** 
105 / mL 0.93 ± 0.13* -1.01 ± 0.47* 1.50 ± 0.06* -1.07  ± 0.07* 
104 / mL 0.63 ± 0.38* -1.50 ± 0.39* 1.16 ± 0.08* -0.61  ± 0.09* 
 N/A – not applied 
 
Farnesol induced cell release from biofilms of clinical strains  
The data indicate that farnesol induces strain-dependent cell detachment from established biofilm. To 
understand whether the reported different bacterial responses to farnesol were associated with different 
strain genetic backgrounds, we test the effect of farnesol in a collection of well characterized 
nosocomial S. epidermidis clinical isolates. Some strains were previously characterized regarding 
genetic typing 13 while others were only analysed for biofilm formation ability 14. For this study all strains 
were screened by MLST, SSCmec, the presence of biofilm formation associated genes (icaA, aap, bhp) 
and the ability to form biofilms (Table 2).Of the 36 strains used in this study, 20 were biofilm positive 
(55.6%) and icaA was detected in 19 strains (52.7% incidence), aap in 20 strains (55.6% incidence) 
and bhp in 13 strains (36.1 % incidence). Farnesol-induced cell detachment was detected in 10 of the 
20 biofilm-forming strains (50% incidence). No correlation was found between the effect of farnesol and 
a specific genetic background. 
 
Discussion 
S. epidermidis currently ranks the first among the causative agents of biofilm-related nosocomial 
infections1. Due to the high antibiotic resistance found in these microorganisms, the search for new 
antimicrobial agents has increased in recent years15. Farnesol is one of the compounds that has been 
tested for antimicrobial potential in several bacterial species. On an early report, we demonstrated that 
while a concentration as low as 30 µM of farnesol was able to kill actively growing planktonic cells, only 
concentrations as high as 300 µM of farnesol was able to reduce established biofilm biomass 7. The 
observed decrease in biofilm thickness could be a result of bacterial death or bacterial dispersion from 
the biofilm. To address this issue we analysed 3 complementary parameters of biofilm physiology and 
demonstrated that while biofilm biomass could be reduced, resulting on an increased concentration of 
bacteria living as planktonic cells, total number of cultivable bacteria was not affected.  
While the exact mechanism of action of farnesol is yet unkown, Inoue et al. demonstrated that farnesol 
antimicrobial mechanism has been linked to cell membrane integrity 8. Furthermore, we have also 
shown that farnesol has a somewhat similar effect as vancomycin 9, which is known to be less effective 
in non-growing cells and high density populations, such as biofilms. To better understand the inability of 
farnesol to kill biofilm bacteria, the effect of cell metabolism and cell density was addressed. As many  
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Table 2 | Phenotypic and molecular characterization of the S. epidermidis strains used, and 
farnesol-mediated cell release.  
 
Strain SCCmec typing ST CC Biofilm genes Biofilm formation Farnesol induced cell release 
1457 MSSE 86 2 ica, aap, bhp +++ - 
9142 II 10 2 ica, aap, bhp +++ + 
COB17 33 33 33 n/d - n/a 
CV45 IV 79 2 ica, bap - n/a 
DEN110 IV 68 66 aap - n/a 
DEN116 I 42 2 n/d - n/a 
DEN120 A/C 40 2 n/d - n/a 
DEN185 IV 21 2 aap, bhp ++ + 
DEN19 IV 1 2 aap - n/a 
DEN69 V 56 S56 ica +++ + 
DEN94 IV 49 247 n/d - n/a 
FJ6  MSSE 10 2 ica, aap bhp + - 
GRE26 IV 11 11 n/d - n/a 
HUR51 B/3 47 33 n/d - n/a 
ICE102 IV 52 2 aap, bhp ++ - 
ICE192 IV 5 2 aap, bhp - n/a 
ICE20 IV 89 2 ica, aap ++ - 
ICE21  I 36 2 ica, aap ++ + 
ICE24 IV 38 2 aap - n/a 
ICE5 IV 23 2 ica, bhp ++ + 
ICE9  III 6 2 ica, bhp +++ - 
IE186 IV 367* S367 ica, aap +++ - 
IE214 NT 10* 2 ica, aap ++ + 
IE75 IV 1 2 ica, bhp + + 
ITL34 IV 66 66 n/d - n/a 
JI6  III 366* 2 ica, aap, bhp +++ + 
LE7 III 9 2 ica, aap + - 
M129 III 366 2 ica, aap ++ - 
M187 IV 367 S367 ica, bhp ++ - 
MCO150 IV 46 2 aap, bhp - n/a 
MEX37 II 71 11 n/d - n/a 
MEX60 NT/2 61 2 Ica ++ + 
PE9 II 10* 2 ica, aap bhp +++ - 
PLN64 NT/2 64 247 n/d - n/a 
TAW113  MS 85 2 aap ++ + 
URU23 IV 86 2 ica, aap +++ - 
*inferred due to similarity of PFGE macrorestriction pattern. n/a – non applied; n/d – none detected)  
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other antibiotics that target cell-wall synthesis, such as vancomycin, the cell-density and cell physiology 
have been widely described in the literature 16. Similar to vancomycin, our results confirm that farnesol 
is also cell-density dependent with reduced reducing bactericidal activity on cell densities above 10E8 
CFU/mL. Interestingly, contrary to vancomycin, farnesol seemed not to be cell-physiology dependent, 
since the same effect was found on stationary or log-phase grown cells. 
In order to analyze whether a genetic background could be associated with the reported strain to strain 
variable responses to farnesol, we determined farnesol induced biofilm detachment using a collection of 
well characterized nosocomial S. epidermidis isolates. Interestingly all the strongest biofilm-forming 
strains presented at least the icaA gene. A similar result was described by Rodhe et al. in a collection of 
51 clinical isolates of S. epidermidis17. Despite no correlation  between the effect of farnesol and a 
specific genetic background, farnesol was able to detach cells from the biofilm of nine strains tested 
belonging to clonal complex 2 (CC2), which is the main clonal lineage in hospitals worldwide. The 
results suggest that other phenomena independent of the genetic background, such as the overall 
metabolism or the type of biofilm formed may influence the outcome of farnesol in clinical S. 
epidermidis isolates. Nevertheless it was observed activity against S. epidermidis of highly clinical and 
epidemiological relevance which clearly substantiate its use in the future. 
Our previous findings regarding the role of farnesol as an adjuvant in antimicrobial chemotherapy 18 can 
now be better explained. We hypothesized that despite the inability of farnesol to kill the bacteria inside 
biofilms, by inducing, via a yet unknown mechanism, cell detachment from biofilms, the suspended 
bacteria will be potentially more susceptible to antibiotic attack, taking into consideration that no 
diffusion barrier would be present in such cases. While we did not address this issue, it would be 
interesting to determine the role of farnesol over longer periods of time, in order to access its effect of 
mature biofilms. Furthermore, to better understand the molecular mechanisms underlying farnesol 
mode of action, it would be important to test different concentrations of farnesol, including sub-MIC 
concentrations. 
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